Role of Nijmegen Breakage Syndrome Protein in Specific T-Lymphocyte Activation Pathways
Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Clinical and Diagnostic Laboratory Immunology 2001-07, Vol.8 (4), p.757-761 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 761 |
|---|---|
| container_issue | 4 |
| container_start_page | 757 |
| container_title | Clinical and Diagnostic Laboratory Immunology |
| container_volume | 8 |
| creator | Miguel Angel Garcı́a-Pérez Luis M. Allende Alfredo Corell Estela Paz-Artal Pilar Varela Alberto López-Goyanes Francisco Garcı́a-Martin Rosario Vázquez Amalia Sotoca Antonio Arnaiz-Villena |
| description | Classifications
Services
CVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
CVI
About
CVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
CVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
1556-6811
Online ISSN:
1556-679X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
CVI
.asm.org, visit:
CVI
|
| doi_str_mv | 10.1128/CDLI.8.4.757-761.2001 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18079016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18079016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c461t-914e8d546a829aa962f182b09bca003e4241beb613c5ccfe81fcaa04c448d1d03</originalsourceid><addsrcrecordid>eNpVkd1q3DAQhUVoSdIkj9Ciq97Z1ciyLENv0k3aBpY2JCnNnZDl8VqpbW0kb4Lfvl520x8YmIE558zAR8hbYCkAVx8WF8urVKUiLfIiKSSknDE4IMeQ5zKRRXn_6mVWAEfkTYwPjIlMquKQHAEIXgjOj8nPG98h9Q395h56XOFAPwU0v8wK6e001MH3SK-DH9ENdK7bNVrXOEvvkuXUr1tvpxHpuR3dkxmdH-i1GdtnM8VT8roxXcSzfT8hPz5f3i2-JsvvX64W58vECgljUoJAVedCGsVLY0rJG1C8YmVlDWMZCi6gwkpCZnNrG1TQWGOYsEKoGmqWnZCPu9z1puqxtjiMwXR6HVxvwqS9cfr_zeBavfJPupwz1Wx_v7cH_7jBOOreRYtdZwb0m6hBsaJkIGdhvhPa4GMM2Pw5AUxvgegtEK200DMQPQPRWyCz792___117QnMAroTtG7VPruA2sRe27pzL2HZb2yQlIU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18079016</pqid></control><display><type>article</type><title>Role of Nijmegen Breakage Syndrome Protein in Specific T-Lymphocyte Activation Pathways</title><source>MEDLINE</source><source>American Society for Microbiology Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Miguel Angel Garcı́a-Pérez ; Luis M. Allende ; Alfredo Corell ; Estela Paz-Artal ; Pilar Varela ; Alberto López-Goyanes ; Francisco Garcı́a-Martin ; Rosario Vázquez ; Amalia Sotoca ; Antonio Arnaiz-Villena</creator><creatorcontrib>Miguel Angel Garcı́a-Pérez ; Luis M. Allende ; Alfredo Corell ; Estela Paz-Artal ; Pilar Varela ; Alberto López-Goyanes ; Francisco Garcı́a-Martin ; Rosario Vázquez ; Amalia Sotoca ; Antonio Arnaiz-Villena</creatorcontrib><description>Classifications
Services
CVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
CVI
About
CVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
CVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
1556-6811
Online ISSN:
1556-679X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
CVI
.asm.org, visit:
CVI
</description><identifier>ISSN: 1556-6811</identifier><identifier>ISSN: 1071-412X</identifier><identifier>EISSN: 1556-679X</identifier><identifier>EISSN: 1098-6588</identifier><identifier>DOI: 10.1128/CDLI.8.4.757-761.2001</identifier><identifier>PMID: 11427422</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>B-Lymphocytes - immunology ; CD3 antigen ; CD4 antigen ; CD4-Positive T-Lymphocytes - drug effects ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - drug effects ; CD8-Positive T-Lymphocytes - immunology ; Cell Cycle Proteins - genetics ; Cell Cycle Proteins - immunology ; Child ; Chromosome Breakage - immunology ; Humans ; Immune-Mediated Responses and Disorders ; Karyotyping ; Lectins - metabolism ; Lymphocyte Activation - immunology ; Male ; Mitogens - pharmacology ; Mutation ; Nijmegen breakage syndrome protein ; Nuclear Proteins ; Syndrome ; T-Lymphocytes - drug effects ; T-Lymphocytes - immunology ; Tetradecanoylphorbol Acetate - pharmacology</subject><ispartof>Clinical and Diagnostic Laboratory Immunology, 2001-07, Vol.8 (4), p.757-761</ispartof><rights>Copyright © 2001, American Society for Microbiology 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c461t-914e8d546a829aa962f182b09bca003e4241beb613c5ccfe81fcaa04c448d1d03</citedby><cites>FETCH-LOGICAL-c461t-914e8d546a829aa962f182b09bca003e4241beb613c5ccfe81fcaa04c448d1d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC96138/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC96138/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3188,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11427422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miguel Angel Garcı́a-Pérez</creatorcontrib><creatorcontrib>Luis M. Allende</creatorcontrib><creatorcontrib>Alfredo Corell</creatorcontrib><creatorcontrib>Estela Paz-Artal</creatorcontrib><creatorcontrib>Pilar Varela</creatorcontrib><creatorcontrib>Alberto López-Goyanes</creatorcontrib><creatorcontrib>Francisco Garcı́a-Martin</creatorcontrib><creatorcontrib>Rosario Vázquez</creatorcontrib><creatorcontrib>Amalia Sotoca</creatorcontrib><creatorcontrib>Antonio Arnaiz-Villena</creatorcontrib><title>Role of Nijmegen Breakage Syndrome Protein in Specific T-Lymphocyte Activation Pathways</title><title>Clinical and Diagnostic Laboratory Immunology</title><addtitle>Clin Diagn Lab Immunol</addtitle><description>Classifications
Services
CVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
CVI
About
CVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
CVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
1556-6811
Online ISSN:
1556-679X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
CVI
.asm.org, visit:
CVI
</description><subject>B-Lymphocytes - immunology</subject><subject>CD3 antigen</subject><subject>CD4 antigen</subject><subject>CD4-Positive T-Lymphocytes - drug effects</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - drug effects</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Cell Cycle Proteins - genetics</subject><subject>Cell Cycle Proteins - immunology</subject><subject>Child</subject><subject>Chromosome Breakage - immunology</subject><subject>Humans</subject><subject>Immune-Mediated Responses and Disorders</subject><subject>Karyotyping</subject><subject>Lectins - metabolism</subject><subject>Lymphocyte Activation - immunology</subject><subject>Male</subject><subject>Mitogens - pharmacology</subject><subject>Mutation</subject><subject>Nijmegen breakage syndrome protein</subject><subject>Nuclear Proteins</subject><subject>Syndrome</subject><subject>T-Lymphocytes - drug effects</subject><subject>T-Lymphocytes - immunology</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><issn>1556-6811</issn><issn>1071-412X</issn><issn>1556-679X</issn><issn>1098-6588</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkd1q3DAQhUVoSdIkj9Ciq97Z1ciyLENv0k3aBpY2JCnNnZDl8VqpbW0kb4Lfvl520x8YmIE558zAR8hbYCkAVx8WF8urVKUiLfIiKSSknDE4IMeQ5zKRRXn_6mVWAEfkTYwPjIlMquKQHAEIXgjOj8nPG98h9Q395h56XOFAPwU0v8wK6e001MH3SK-DH9ENdK7bNVrXOEvvkuXUr1tvpxHpuR3dkxmdH-i1GdtnM8VT8roxXcSzfT8hPz5f3i2-JsvvX64W58vECgljUoJAVedCGsVLY0rJG1C8YmVlDWMZCi6gwkpCZnNrG1TQWGOYsEKoGmqWnZCPu9z1puqxtjiMwXR6HVxvwqS9cfr_zeBavfJPupwz1Wx_v7cH_7jBOOreRYtdZwb0m6hBsaJkIGdhvhPa4GMM2Pw5AUxvgegtEK200DMQPQPRWyCz792___117QnMAroTtG7VPruA2sRe27pzL2HZb2yQlIU</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>Miguel Angel Garcı́a-Pérez</creator><creator>Luis M. Allende</creator><creator>Alfredo Corell</creator><creator>Estela Paz-Artal</creator><creator>Pilar Varela</creator><creator>Alberto López-Goyanes</creator><creator>Francisco Garcı́a-Martin</creator><creator>Rosario Vázquez</creator><creator>Amalia Sotoca</creator><creator>Antonio Arnaiz-Villena</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20010701</creationdate><title>Role of Nijmegen Breakage Syndrome Protein in Specific T-Lymphocyte Activation Pathways</title><author>Miguel Angel Garcı́a-Pérez ; Luis M. Allende ; Alfredo Corell ; Estela Paz-Artal ; Pilar Varela ; Alberto López-Goyanes ; Francisco Garcı́a-Martin ; Rosario Vázquez ; Amalia Sotoca ; Antonio Arnaiz-Villena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c461t-914e8d546a829aa962f182b09bca003e4241beb613c5ccfe81fcaa04c448d1d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>B-Lymphocytes - immunology</topic><topic>CD3 antigen</topic><topic>CD4 antigen</topic><topic>CD4-Positive T-Lymphocytes - drug effects</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - drug effects</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Cell Cycle Proteins - genetics</topic><topic>Cell Cycle Proteins - immunology</topic><topic>Child</topic><topic>Chromosome Breakage - immunology</topic><topic>Humans</topic><topic>Immune-Mediated Responses and Disorders</topic><topic>Karyotyping</topic><topic>Lectins - metabolism</topic><topic>Lymphocyte Activation - immunology</topic><topic>Male</topic><topic>Mitogens - pharmacology</topic><topic>Mutation</topic><topic>Nijmegen breakage syndrome protein</topic><topic>Nuclear Proteins</topic><topic>Syndrome</topic><topic>T-Lymphocytes - drug effects</topic><topic>T-Lymphocytes - immunology</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miguel Angel Garcı́a-Pérez</creatorcontrib><creatorcontrib>Luis M. Allende</creatorcontrib><creatorcontrib>Alfredo Corell</creatorcontrib><creatorcontrib>Estela Paz-Artal</creatorcontrib><creatorcontrib>Pilar Varela</creatorcontrib><creatorcontrib>Alberto López-Goyanes</creatorcontrib><creatorcontrib>Francisco Garcı́a-Martin</creatorcontrib><creatorcontrib>Rosario Vázquez</creatorcontrib><creatorcontrib>Amalia Sotoca</creatorcontrib><creatorcontrib>Antonio Arnaiz-Villena</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and Diagnostic Laboratory Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miguel Angel Garcı́a-Pérez</au><au>Luis M. Allende</au><au>Alfredo Corell</au><au>Estela Paz-Artal</au><au>Pilar Varela</au><au>Alberto López-Goyanes</au><au>Francisco Garcı́a-Martin</au><au>Rosario Vázquez</au><au>Amalia Sotoca</au><au>Antonio Arnaiz-Villena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Nijmegen Breakage Syndrome Protein in Specific T-Lymphocyte Activation Pathways</atitle><jtitle>Clinical and Diagnostic Laboratory Immunology</jtitle><addtitle>Clin Diagn Lab Immunol</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>8</volume><issue>4</issue><spage>757</spage><epage>761</epage><pages>757-761</pages><issn>1556-6811</issn><issn>1071-412X</issn><eissn>1556-679X</eissn><eissn>1098-6588</eissn><abstract>Classifications
Services
CVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
CVI
About
CVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
CVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
1556-6811
Online ISSN:
1556-679X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
CVI
.asm.org, visit:
CVI
</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>11427422</pmid><doi>10.1128/CDLI.8.4.757-761.2001</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1556-6811 |
| ispartof | Clinical and Diagnostic Laboratory Immunology, 2001-07, Vol.8 (4), p.757-761 |
| issn | 1556-6811 1071-412X 1556-679X 1098-6588 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_18079016 |
| source | MEDLINE; American Society for Microbiology Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | B-Lymphocytes - immunology CD3 antigen CD4 antigen CD4-Positive T-Lymphocytes - drug effects CD4-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - drug effects CD8-Positive T-Lymphocytes - immunology Cell Cycle Proteins - genetics Cell Cycle Proteins - immunology Child Chromosome Breakage - immunology Humans Immune-Mediated Responses and Disorders Karyotyping Lectins - metabolism Lymphocyte Activation - immunology Male Mitogens - pharmacology Mutation Nijmegen breakage syndrome protein Nuclear Proteins Syndrome T-Lymphocytes - drug effects T-Lymphocytes - immunology Tetradecanoylphorbol Acetate - pharmacology |
| title | Role of Nijmegen Breakage Syndrome Protein in Specific T-Lymphocyte Activation Pathways |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T00%3A15%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Nijmegen%20Breakage%20Syndrome%20Protein%20in%20Specific%20T-Lymphocyte%20Activation%20Pathways&rft.jtitle=Clinical%20and%20Diagnostic%20Laboratory%20Immunology&rft.au=Miguel%20Angel%20Garc%C4%B1%CC%81a-P%C3%A9rez&rft.date=2001-07-01&rft.volume=8&rft.issue=4&rft.spage=757&rft.epage=761&rft.pages=757-761&rft.issn=1556-6811&rft.eissn=1556-679X&rft_id=info:doi/10.1128/CDLI.8.4.757-761.2001&rft_dat=%3Cproquest_cross%3E18079016%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18079016&rft_id=info:pmid/11427422&rfr_iscdi=true |